Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

A practice-based research network focused on comparative effectiveness research in type 2 diabetes management.

Anderson JE, Rhinehart AS, Reid TS, Cuddihy RM, Vlajnic A, Dalal MR, Gemmen E, Johnstone B, Abbaszadeh B, Reed J, Sheller J, Stewart J, Mozaffari E; Diabetes FORWARD Investigators.

Postgrad Med. 2013 May;125(3):172-80. doi: 10.3810/pgm.2013.05.2658.

PMID:
23748518
2.

Comparative effectiveness research in DARTNet primary care practices: point of care data collection on hypoglycemia and over-the-counter and herbal use among patients diagnosed with diabetes.

Libby AM, Pace W, Bryan C, Anderson HO, Ellis SL, Allen RR, Brandt E, Huebschmann AG, West D, Valuck RJ.

Med Care. 2010 Jun;48(6 Suppl):S39-44. doi: 10.1097/MLR.0b013e3181ddc7b0.

PMID:
20473193
3.

Electronic health record use to classify patients with newly diagnosed versus preexisting type 2 diabetes: infrastructure for comparative effectiveness research and population health management.

Kudyakov R, Bowen J, Ewen E, West SL, Daoud Y, Fleming N, Masica A.

Popul Health Manag. 2012 Feb;15(1):3-11. doi: 10.1089/pop.2010.0084. Epub 2011 Aug 30.

PMID:
21877923
4.

Evaluation of the quality of care of a multi-disciplinary risk factor assessment and management programme (RAMP) for diabetic patients.

Fung CS, Chin WY, Dai DS, Kwok RL, Tsui EL, Wan YF, Wong W, Wong CK, Fong DY, Lam CL.

BMC Fam Pract. 2012 Dec 5;13:116. doi: 10.1186/1471-2296-13-116.

5.

The London low emission zone baseline study.

Kelly F, Armstrong B, Atkinson R, Anderson HR, Barratt B, Beevers S, Cook D, Green D, Derwent D, Mudway I, Wilkinson P; HEI Health Review Committee.

Res Rep Health Eff Inst. 2011 Nov;(163):3-79.

PMID:
22315924
6.

Patients' education, and its impact on care outcomes, resource consumption and working conditions: data from the International Diabetes Management Practices Study (IDMPS).

Gagliardino JJ, Aschner P, Baik SH, Chan J, Chantelot JM, Ilkova H, Ramachandran A; IDMPS investigators.

Diabetes Metab. 2012 Apr;38(2):128-34. doi: 10.1016/j.diabet.2011.09.002. Epub 2011 Oct 22.

PMID:
22019715
7.

Using electronic medical records analysis to investigate the effectiveness of lifestyle programs in real-world primary care is challenging: a case study in diabetes mellitus.

Linmans JJ, Viechtbauer W, Koppenaal T, Spigt M, Knottnerus JA.

J Clin Epidemiol. 2012 Jul;65(7):785-92. doi: 10.1016/j.jclinepi.2012.01.010. Epub 2012 May 3.

PMID:
22560776
8.

The uses of outcomes research for medical effectiveness, quality of care, and reimbursement in type II diabetes.

Greenfield S, Kaplan SH, Silliman RA, Sullivan L, Manning W, D'Agostino R, Singer DE, Nathan DM.

Diabetes Care. 1994 Jun;17 Suppl 1:32-9. Review.

PMID:
8088221
9.

Comparative effectiveness of asthma interventions within a practice based research network.

Tapp H, Hebert L, Dulin M.

BMC Health Serv Res. 2011 Aug 16;11:188. doi: 10.1186/1472-6963-11-188. Review.

10.

Ethical pitfalls in neonatal comparative effectiveness trials.

Modi N.

Neonatology. 2014;105(4):350-1. doi: 10.1159/000360650. Epub 2014 May 30.

PMID:
24931328
11.

Decision support tools to optimize economic outcomes for type 2 diabetes.

Shaya FT, Chirikov VV.

Am J Manag Care. 2011 Nov;17 Suppl 14:S377-83.

12.

Management of newly diagnosed type 2 Diabetes Mellitus (T2DM) in children and adolescents.

Copeland KC, Silverstein J, Moore KR, Prazar GE, Raymer T, Shiffman RN, Springer SC, Thaker VV, Anderson M, Spann SJ, Flinn SK; American Academy of Pediatrics.

Pediatrics. 2013 Feb;131(2):364-82. doi: 10.1542/peds.2012-3494. Epub 2013 Jan 28. Erratum in: Pediatrics. 2013 May;131(5):1014.

13.

Management of type 2 diabetes mellitus in children and adolescents.

Springer SC, Silverstein J, Copeland K, Moore KR, Prazar GE, Raymer T, Shiffman RN, Thaker VV, Anderson M, Spann SJ, Flinn SK; American Academy of Pediatrics.

Pediatrics. 2013 Feb;131(2):e648-64. doi: 10.1542/peds.2012-3496. Epub 2013 Jan 28. Review. Erratum in: Pediatrics. 2013 May;131(5):1014.

14.

Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis.

Tricco AC, Antony J, Soobiah C, Hemmelgarn B, Moher D, Hutton B, Yu CH, Majumdar SR, Straus SE.

Syst Rev. 2013 Jun 28;2:47. doi: 10.1186/2046-4053-2-47.

15.

Community-based care for the management of type 2 diabetes: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(23):1-40. Epub 2009 Oct 1.

16.

Adoption and implementation of strategies for diabetes management in primary care practices.

Weiner BJ, Helfrich CD, Savitz LA, Swiger KD.

Am J Prev Med. 2007 Jul;33(1 Suppl):S35-44; quiz S45-9.

PMID:
17584590
17.

Relationships among self-management, patient perceptions of care, and health economic outcomes for decision-making and clinical practice in type 2 diabetes.

Cobden DS, Niessen LW, Barr CE, Rutten FF, Redekop WK.

Value Health. 2010 Jan-Feb;13(1):138-47. doi: 10.1111/j.1524-4733.2009.00587.x. Epub 2009 Aug 20. Review.

18.

The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.

McGhan WF, Al M, Doshi JA, Kamae I, Marx SE, Rindress D.

Value Health. 2009 Nov-Dec;12(8):1086-99. doi: 10.1111/j.1524-4733.2009.00605.x. Epub 2009 Sep 10.

19.

Prandial insulin versus glucagon-like peptide-1 added to basal insulin: comparative effectiveness in the community practice setting.

Digenio A, Karve S, Candrilli SD, Dalal M.

Postgrad Med. 2014 Oct;126(6):49-59. doi: 10.3810/pgm.2014.10.2820.

PMID:
25414934
20.

Impact of population management with direct physician feedback on care of patients with type 2 diabetes.

Grant RW, Hamrick HE, Sullivan CM, Dubey AK, Chueh HC, Cagliero E, Meigs JB.

Diabetes Care. 2003 Aug;26(8):2275-80.

PMID:
12882848

Supplemental Content

Support Center